Turning a Patent Into Actual Revenue

A granted patent is a receipt, not a business. It grants the right to stop others from making, using, or selling the claimed invention in the United States — and nothing else. No one is obligated to pay you, and no company has a process for cutting checks to strangers with paperwork. Technology transfer is the work of converting that legal right into cash, and it is a commercial exercise with an engineering prerequisite, not a legal one.

The three routes out of a patent

There are only three, and they have very different capital requirements.

Most inventors assume licensing is the low-effort option. It is not. It is the option with the lowest capital requirement and the highest sales requirement. How a patent license deal is structured and what an outright patent sale involves cover the mechanics of the second and third rows.

What a licensee is actually buying

Companies do not license patents. They license de-risked opportunities that happen to be protected by patents. When a product manager at a mid-size manufacturer evaluates your technology, the questions in the room are:

• Does this solve a problem our customers already complain about?
• Can our existing line make it, or does it need new tooling?
• What is the landed cost per unit at our volumes?
• Has anyone built one that works, and for how long has it run?
• If we launch it, does your patent actually stop our competitors from following?

Only the last question is about the patent. The other four are engineering and manufacturing questions, and they are the ones that kill most deals. A concept sketch plus a granted claim set answers none of them.

The readiness package

Before you approach anyone, assemble the material that answers those questions. In practice a licensable package includes:

1. A working prototype that survives a demonstration without an explanation. If the demo needs a caveat, it is not ready.
2. Test data against the incumbent solution — cycles, load, accuracy, runtime, whatever metric the buyer's customers care about.
3. A manufacturing cost estimate at two or three volume points, with the process named. Estimating manufacturing cost before tooling exists shows how to build that number credibly.
4. A claim chart in plain English mapping your independent claims onto the product the licensee would sell.
5. Clean documentation of ownership — recorded assignments, signed contractor agreements, no unresolved co-inventor claims.
6. A regulatory read if the field needs one: FDA classification, FCC equipment authorization, UL listing path.

The move from a bench prototype to something a licensee can evaluate is a real project with a real budget, and it is the step most patents die on. Going from prototype to production describes what that transition actually involves.

Finding the right counterparty

The best licensee is rarely the biggest company in the category. Market leaders have full pipelines and internal engineering teams that prefer their own ideas. The second and third players — companies with distribution but a thinner product roadmap — have a stronger reason to take an outside technology.

Build a target list from the patent record itself: search for who is filing in your CPC subclass, who cites the same prior art, and who has recently launched an adjacent product. Then approach through business development, not the legal department. Legal's job is to say no.

Universities and federally funded work

If your invention touched a university lab or a federal grant, the ownership picture changes before any deal is possible. Bayh-Dole election requirements, government march-in rights, and SBIR data rights all attach to the technology. Sort that out first — who owns IP from a federal grant covers the rules, and partnering with universities on product R&D explains how tech transfer offices structure their side.

Deal terms that decide whether you get paid

• Upfront payment. Small for early-stage technology, often $10,000–$100,000. Its real function is to prove the licensee is serious.
• Running royalty. Usually a percentage of net sales, defined carefully — net of what, exactly, matters more than the percentage.
• Minimum annual royalties. The single most important clause for an inventor. Without minimums, a licensee can take an exclusive license and shelve the technology forever.
• Field and territory limits. Grant exclusivity only in the field the licensee will actually work. Keep the rest.
• Milestones and reversion. Named dates for first commercial sale, with rights reverting to you if they slip.
• Improvement rights. Who owns what you invent next, and what they owe you for it.
• Sublicensing and audit rights. You cannot enforce a royalty you cannot verify.

A patent attorney should paper the agreement. Before that, decide what the technology is worth on your own terms; valuing a patent before you license or sell it gives you the three standard methods so you are not anchored by the first offer.

Why most transfers fail

The recurring causes are narrow: the claims cover the prototype rather than the commercial embodiment, the cost per unit was never calculated so the licensee's margin analysis fails, ownership is clouded by an unsigned contractor agreement, or the inventor insisted on an exclusive worldwide license with no minimums and then waited five years for a royalty that never came. Every one of those is preventable before the first meeting.

Projects House builds the technical half of that package — working prototypes, test data, manufacturing cost models, and production-ready documentation that a licensee's engineering team can evaluate without guessing. The license itself belongs with your patent attorney. If you have a granted patent and no way to show what it does, describe it through our contact form and we will tell you what it would take to make it demonstrable.